The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Fucosyltransferase 2 (FUT2) non-secretor status and blood group B are associated with elevated serum lipase activity in asymptomatic subjects, and an increased risk for chronic pancreatitis: a genetic association study
Abstract
OBJECTIVE: Serum lipase activities above the threefold upper reference limit indicate acute pancreatitis. We investigated whether high lipase activity-within the reference range and in the absence of pancreatitis-are associated with genetic single nucleotide polymorphisms (SNP), and whether these identified SNPs are also associated with clinical pancreatitis. METHODS: Genome-wide association studies (GWAS) on phenotypes 'serum lipase activity' and 'high serum lipase activity' were conducted including 3966 German volunteers from the population-based Study-of-Health-in-Pomerania (SHIP). Lead SNPs associated on a genome-wide significance level were replicated in two cohorts, 1444 blood donors and 1042 pancreatitis patients. RESULTS: Initial discovery GWAS detected SNPs within or near genes encoding the ABO blood group specifying transferases A/B (ABO), Fucosyltransferase-2 (FUT2), and Chymotrypsinogen-B2 (CTRB2), to be significantly associated with lipase activity levels in asymptomatic subjects. Replication analyses in blood donors confirmed the association of FUT-2 non-secretor status (OR=1.49; p=0.012) and ABO blood-type-B (OR=2.48; p=7.29×10(-8)) with high lipase activity levels. In pancreatitis patients, significant associations were found for FUT-2 non-secretor status (OR=1.53; p=8.56×10(-4)) and ABO-B (OR=1.69, p=1.0×10(-4)) with chronic pancreatitis, but not with acute pancreatitis. Conversely, carriers of blood group O were less frequently affected by chronic pancreatitis (OR=0.62; p=1.22×10(-05)) and less likely to have high lipase activity levels (OR=0.59; p=8.14×10(-05)). CONCLUSIONS: These are the first results indicating that ABO blood type-B as well as FUT2 non-secretor status are common population-wide risk factors for developing chronic pancreatitis. They also imply that, even within the reference range, elevated lipase activities may indicate subclinical pancreatic injury in asymptomatic subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
IAP/APA evidence-based guidelines for the management of acute pancreatitis
Working Group IAP/APA Acute Pancreatitis Guidelines (2013) · Pancreatology · doi:10.1016/j.pan.2013.07.063 · Cited by 2,075
Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R., Lankisch, P. G., Andersen, J. R., DiMagno, E. P., Andrén‐Sandberg, Å., & Domellöf, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,753
Cohort Profile: The Study of Health in Pomerania
Völzke, H., Alte, D., Schmidt, C. O., Radke, D., Lorbeer, R., Friedrich, N., Aumann, N., Lau, K., Piontek, K., Born, G., et al. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp394 · Cited by 1,006
Self-citationThe effect of ABO blood group on the diagnosis of von Willebrand disease
Gill, J., Endres-Brooks, J., Bauer, P., Marks, W. J., & Montgomery, R. (1987) · Blood · doi:10.1182/blood.v69.6.1691.1691 · Cited by 954
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations
Study, L. C., Köttgen, A., Albrecht, E., Teumer, A., Vitart, V., Krumsiek, J., Hundertmark, C., Pistis, G., Ruggiero, D., O’Seaghdha, C. M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2500 · Cited by 834
Self-citationPe'er, I., Yelensky, R., Altshuler, D., & Daly, M. J. (2008) · Genetic Epidemiology · doi:10.1002/gepi.20303 · Cited by 783
Amundadottir, L. T., Kraft, P. L., Stolzenberg‐Solomon, R. Z., Fuchs, C. S., Petersen, G. M., Arslan, A. A., Bueno-de-Mesquita, H. B., Gross, M., Helzlsouer, K. J., Jacobs, E. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.429 · Cited by 710
Kelly, R. J., Rouquier, S., Giorgi, D., Lennon, G. G., & Lowe, J. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4640 · Cited by 573
Reilly, M. P., Li, M., He, J., Ferguson, J. F., Stylianou, I. M., Mehta, N. N., Burnett, M. S., Devaney, J. M., Knouff, C. W., Thompson, J. R., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61996-4 · Cited by 547
Flagged first, then by citations
Cited by
Sorted by citations
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Beyond the clinically obvious CDGs, there is also increasing genetic evidence for the role of glycosylation-related genes in more subtle and common diseases in the population, as observed in genome wide association studies a few examples of which are mentioned here: NDST3 (390) and ST8SIA2 (391–393) in schizophrenia a…”
BackgroundHost genetic regulation of human gut microbial structural variation
Zhernakova, D. V., Wang, D., Liu, L., Andreu-Sánchez, S., Zhang, Y., Ruiz-Moreno, A. J., Peng, H., Plomp, N., Del Castillo-Izquierdo, Á., Gacesa, R., et al. (2024) · Nature · doi:10.1038/s41586-023-06893-w · Cited by 174
Metadata
- Authors
- Weiss, F. U., Schurmann, C., Guenther, A., Ernst, F., Teumer, A., Mayerle, J., Simon, P., Völzke, H., Radke, D., Greinacher, A., Kuehn, J.-P., Zenker, M., Völker, U., Homuth, G., & Lerch, M. M.
- Affiliations
- Universitätsmedizin Greifswald (DE)
- University Hospital Magdeburg (DE)
- Corresponding author
- Lerch, Markus M
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2014-07-15
- Volume
- 64
- Issue
- 4
- Pages
- 646-656
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2143278956
- Cited by
- 88
- References
- 44
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 9 · 2022: 7 · 2021: 4 · 2020: 8 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 10 · 2015: 8 · 2014: 1
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- ABO blood group system, blood group B, serum lipase activity, chronic pancreatitis, acute pancreatitis, genetic susceptibility, single nucleotide polymorphisms
- MeSH terms
- ABO Blood-Group System, Galactoside 2-alpha-L-fucosyltransferase, Adult, Aged, Aged, 80 and over, Female, Fucosyltransferases, Humans, Lipase, Male, Middle Aged, Risk Assessment, Polymorphism, Single Nucleotide, Pancreatitis, Chronic, Genome-Wide Association Study, Young Adult, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review